{
    "clinical_study": {
        "@rank": "13185", 
        "arm_group": [
            {
                "arm_group_label": "OSA without PFO", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "OSA with PFO", 
                "arm_group_type": "Other", 
                "description": "PFO closure"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study in patients with obstructive sleep apnoea (OSA) and concomitant\n      patent foramen ovale (PFO) is to assess the impact of percutaneous PFO closure on nocturnal\n      hypoxemia and apnea/hypopnea,  pulmonary and systemic artery pressure, endothelial function\n      and arterial stiffness."
        }, 
        "brief_title": "Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea", 
        "condition": "Obstructive Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Foramen Ovale, Patent", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with newly diagnosed moderate to severe OSA\n\n          -  Age > 17 years\n\n          -  Written informed consent for study participation.\n\n        Exclusion Criteria:\n\n          -  Patients with other pulmonary disease associated with oxygen desaturation (other than\n             obesity-associated pulmonary restriction)\n\n          -  Patients with central sleep apnea syndrome\n\n          -  Patients with other causes of pulmonary hypertension\n\n          -  Intracardiac shunt other than via PFO\n\n          -  Severe valvular heart disease\n\n          -  Abnormal left ventricular (LV) systolic function (ejection fraction <50%)\n\n          -  Obesity with BMI > 40\n\n          -  Contraindication to TOE\n\n          -  Severe pulmonary  arterial hypertension (mean pulmonary artery pressure > 45 mmHg)"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "January 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01780207", 
            "org_study_id": "066/10"
        }, 
        "intervention": {
            "arm_group_label": "OSA with PFO", 
            "intervention_name": "PFO Closure", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 29, 2013", 
        "location": {
            "contact": {
                "email": "stefano.rimoldi@insel.ch", 
                "last_name": "Stefano Rimoldi, MD", 
                "phone": "+41316322111"
            }, 
            "facility": {
                "address": {
                    "city": "Bern", 
                    "country": "Switzerland", 
                    "zip": "3010"
                }, 
                "name": "University Hospital Bern"
            }, 
            "investigator": {
                "last_name": "Stefano Rimoldi, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "official_title": "Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea", 
        "overall_contact": {
            "email": "stefano.rimoldi@insel.ch", 
            "last_name": "Stefano Rimoldi, MD", 
            "phone": "+41316322111"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkomission"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Apnea Hypopnea Index (AHI), apnea index (changes from baseline to follow-up)", 
            "time_frame": "0, 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01780207"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Inselspital, Berne", 
            "investigator_full_name": "Christian Seiler", 
            "investigator_title": "MD Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Systemic vascular assessment", 
            "time_frame": "0, 3 months"
        }, 
        "source": "University Hospital Inselspital, Berne", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Inselspital, Berne", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}